A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2002
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1264594A2 Melanin production inhibitors and skincare products containing such inhibitors
12/11/2002	EP1264548A2 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263955A2 Polypeptides and nucleic acids encoding same
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263932A1 Embryonic stem cells and neural progenitor cells derived therefrom
12/11/2002	EP1263930A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord
12/11/2002	EP1263884A1 Process for the preparation of micronised collagen, and its therapeutic applications
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs
12/11/2002	EP1263761A2 Compounds for pdt
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263752A2 Lpa receptor agonists and antagonists and methods of use
12/11/2002	EP1263742A1 Oxazolidinone thioamides with piperazine amide substituents
12/11/2002	EP1263737A1 2-phenylcarbamoyl-benzimidazoles
12/11/2002	EP1263736A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263459A2 Attenuation of fibroblast proliferation
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1263426A1 Preparations for the non-traumatic excision of a nail
12/11/2002	EP1263421A2 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
12/11/2002	EP1263394A2 The use of plant extracts and sugars to protect keratinous tissue
12/11/2002	EP1124535B1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP1063969B1 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect
12/11/2002	EP1056716B1 Cyclohexanediole derivatives
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
12/11/2002	CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors
12/11/2002	CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors
12/11/2002	CN1383884A Medicine ointment for eliminating tinea manuum
12/11/2002	CN1383879A Plaster using paper as carrier for treating beriberi
12/11/2002	CN1383873A Dermatosis treating medicine and its prepn
12/11/2002	CN1383862A Natural hair-blackening water
12/11/2002	CN1383849A Burn and scald treating oil
12/11/2002	CN1383844A Wild hibiscus Chinese medicine material and herbal pieces
12/11/2002	CN1383843A Wild hibiscus holographic-essence
12/11/2002	CN1383840A Medicine for treating burns and scales and its prepn process and use
12/11/2002	CN1383834A Beautifying crocodile glue paste
12/11/2002	CN1383812A No-aggregation rush nano silver powder natural medicated cosmetics and industrialized production process thereof
12/11/2002	CN1095659C Bath lotion series with anti-inflammatory, antipruritic and antibiotic functions
12/11/2002	CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum
12/11/2002	CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/11/2002	CA2350005A1 Topical wound therapeutic compositions
12/10/2002	US6492552 Disulfide derivatives useful for treating allergic diseases
12/10/2002	US6492536 Glucocorticoids; antiimflammatory and immunosuppressive agents
12/10/2002	US6492497 Specific binding members for TGFbeta1
12/10/2002	US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems
12/10/2002	US6492425 Inhibitors of transcription factor-NF-κB
12/10/2002	US6492424 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
12/10/2002	US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002	US6492413 For use in therapy of pain, arthritis, fever
12/10/2002	US6492410 Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer
12/10/2002	US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1
12/10/2002	US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof
12/10/2002	US6492395 Topical formulation of alkyl-, phenyl-pyridone
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492327 Isolation of purified TGF- β1 and TGF -β2 from bone tissue
12/10/2002	US6492326 Containing a pentapeptide
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002	US6491933 Personal care articles comprising hotmelt compositions
12/10/2002	US6491904 Topical composition containing human epidermal growth factor
12/10/2002	CA2209695C Use of a polyholoside in a composition to promote desquamation and the composition containing it
12/10/2002	CA2208792C Substituted indazole derivatives
12/10/2002	CA2202924C Use of at least one lipoxygenase inhibitor and at least one cyclo-oxygenase inhibitor to alter the growth of hair
12/08/2002	WO2003000892A1 Gene encoding b protein
12/08/2002	CA2817619A1 Methods of administering anti-tnf.alpha. antibodies
12/08/2002	CA2398093A1 Gene encoding protein b
12/08/2002	CA2385745A1 Methods of administering anti-tnf.alpha. antibodies
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097068A2 Keratinocytes obtained from embryonic stem cells of mammals
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097033A2 Antibodies that immunospecifically bind to trail receptors
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096927A2 Ribozyme based treatment of female reproductive diseases
12/05/2002	WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
12/05/2002	WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors

1 ... 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 ... 1065